Step-by-Step Guide for Manual CPD Points Submission (MMA)

by | 10 April 2026

As Highlights of ASH in Asia-Pacific 2026 (HOA 2026) is not directly accredited within the CPD system, all attendees are required to submit their CPD claims individually after the meeting.

Please follow these Step-by-Step Guide (with Visual Reference) for manual CPD application

Step 1 – Open MMA App

Open the MMA mobile application and navigate to and select Events from the bottom menu.

Step 2 – Select Manual Submission

Scroll to the bottom and select Manual Submission.

Step 3 – Select Manual Submission

Click Create Submission to begin a new CPD request.

Step 4 – Enter Event Details

Complete the fields as follows:

  • Country: United States
  • CPD Category: A1 – Scientific meetings / seminars / conferences
  • CPD Subcategory: c. 2 full days
  • Event Title: Highlights of ASH in Asia Pacific 2026
  • Description: [Suggested] Participation in the Highlights of ASH in Asia-Pacific 2026, an international haematology scientific meeting organised by the American Society of Hematology (ASH) and held in Kuala Lumpur, Malaysia. The meeting brought together delegates from 17 countries, including 200 Malaysian delegates featuring expert-led sessions covering advances in leukaemia, lymphoma, myeloma, thrombosis, transplantation, and emerging therapies.

Step 6 – Upload Supporting Documents

Please upload the following:

  • Event Programme (download the attached jpeg below)
  • Certificate of Attendance (issued in ASH apps, after completion of the evaluation form - please convert to image file)

Important Notes

  • CPD submission should be done after the event
  • Both programme and certificate are required for approval
  • Incomplete submissions may be rejected by MMA

Closing

 Should you encounter any difficulties with submission, please feel free to reach out to the MSH Secretariat.  We hope you found the meeting academically enriching and clinically valuable.

 

Highlights of ASH in Asia-Pacific 2026 (Updated with Program)

Highlights of ASH in Asia-Pacific 2026 (Updated with Program)

by | 7 March 2026

For details kindly go to https://www.hematology.org/meetings/highlights-of-ash-in-asia-pacific

Highlights of ASH Day 1  (Friday, April 10, 2026)

Time Session
8:00 – 8:45 Registration and Exhibits Open
8:45 – 9:00 Welcome & Introductions
9:00 – 9:30
Changing Paradigms of Treatment Approaches for Acute Myeloid Leukemia
Katherine Tarlok, MD — University of Washington, Seattle
 
9:30 – 10:00
Integrating Approved Immunotherapies into Treatment Approaches for Adult B-Precursor Acute Lymphoblastic Leukemia
Adele K. Fielding, MBBS, PhD — Hull York Medical School, England
10:00 – 10:30 Panel Discussion
10:30 – 11:00 Coffee Break (Exhibit Hall)
11:00 – 11:45
From Bench to Bedside: Innovations in Hemoglobinopathy Treatment
Payal Desai, MD — Wake Forest University, USA
Prantar Chakrabarti, MBBS, MD, DNB, DM — Zoho for Healthcare, India
11:45 – 12:15
Artificial Intelligence and Informatics in Hematology
Barbara Lam, MD — Fred Hutchinson Cancer Center, Seattle
12:15 – 12:45 Panel Discussion
12:45 – 2:00 Lunch in Exhibit Hall (All Attendees)
Lunch with the Experts (Ticketed)
2:00 – 3:15
Tumor Board: Evolving Myeloma Treatment Paradigm
Gin Gin Gan, MD — Universiti Malaya, Kuala Lumpur
Shaji Kumar, MD — Mayo Clinic, Rochester
Hang Quach, MBBS, MD — St Vincent's Hospital, Melbourne
3:15 – 3:45 Coffee Break (Exhibit Hall)
3:45 – 4:15
Clinical Features and Management of Histiocytic Neoplasms in the Era of Targeted Therapies
Gaurav Goyal, MD — University of Alabama, Birmingham
4:15 – 4:45
Novel Insights and Emerging Therapies in Immune-Mediated Cytopenias
Michael A. Cole, MD, DPhil — Johns Hopkins Medicine, Baltimore
4:45 – 5:15 Panel Discussion
5:15 – 5:20 Highlights of ASH Day 1 Closing Remarks

Highlights of ASH Day 2  (Saturday, April 11, 2026)

Time Session
8:00 – 8:45 Registration and Exhibits Open
8:45 – 9:00 Welcome & Introductions
9:00 – 9:30
New Frontiers in Bleeding Disorders
Ross Baker, MBBS — Perth Blood Institute, Perth, Australia
9:30 – 10:00
Hematology Through a Gender Lens: Unique and Underrecognized Challenges
Sarah O'Brien, MD, MSc — Nationwide Children's, Columbus, Ohio
10:00 – 10:30 Panel Discussion
10:30 – 11:00 Coffee Break (Exhibit Hall)
11:00 – 12:15
Turning the Tide: Key Cases and Conundrums in Thrombosis Medicine
Lai Heng Lee, MBBS, MD — Singapore General Hospital, Singapore
Ponlapat Rojnuckarin, MD, PhD — Bumrungrad International Hospital, Bangkok
Jeffrey Weitz, MD — McMaster University, Ontario, Canada
12:15 – 1:30 Lunch in the Exhibit Hall (All Attendees)
Lunch with the Experts (Ticketed)
1:30 – 2:00
Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia
Jia Ruan, MD, PhD — Weill Cornell Medicine, New York
2:00 – 2:45
Novel Treatment Strategies in Aggressive Lymphoma
Steven Park, MD — Wake Forest University, Winston-Salem
Eric Tse, MBBS, PhD — Hong Kong University, Hong Kong
2:45 – 3:15 Panel Discussion
3:15 – 3:45 Coffee Break (Exhibit Hall)
3:45 – 4:30
New Horizons in Transplantation and Cellular Therapies in Asia and Beyond
Robert Negrin, MD — Stanford University, California
William Hwang, MBBS — National Cancer Centre & Singapore General Hospital
4:30 – 5:00
Practice Changing Advances in Myelodysplastic Syndromes and Myeloproliferative Neoplasms
Harry Gill Singh, MBBS — HKU Med, Hong Kong
5:00 – 5:30 Panel Discussion
5:30 Highlights of ASH in Asia-Pacific Closing Remarks

MSH Annual General Meeting 2026

by | 5 March 2026

The Malaysian Society of Haematology will convene its Annual General Meeting (AGM) on Thursday, 9th April 2026, at the Shangri-La Hotel, Kuala Lumpur, from 6:00 pm to 8:00 pm.

The meeting will also include the biennial election of the Society’s office bearers.